|
F11R expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.177100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.758900E-04 |
| Normal-vs-Stage2 |
1.304230E-03 |
| Normal-vs-Stage3 |
3.489600E-02 |
| Normal-vs-Stage4 |
3.842600E-03 |
| Stage1-vs-Stage2 |
4.361000E-01 |
| Stage1-vs-Stage3 |
6.510800E-01 |
| Stage1-vs-Stage4 |
3.826400E-01 |
| Stage2-vs-Stage3 |
4.153200E-01 |
| Stage2-vs-Stage4 |
8.238000E-01 |
| Stage3-vs-Stage4 |
4.028800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.808300E-04 |
| Normal-vs-AfricanAmerican |
3.606000E-04 |
| Normal-vs-Asian |
1.803790E-03 |
| Caucasian-vs-AfricanAmerican |
4.072400E-01 |
| Caucasian-vs-Asian |
2.248500E-02 |
| AfricanAmerican-vs-Asian |
2.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.604300E-04 |
| Normal-vs-Female |
1.214410E-01 |
| Male-vs-Female |
7.186000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.956300E-04 |
| Normal-vs-Extreme_Weight |
1.641320E-04 |
| Normal-vs-Obese |
9.138800E-03 |
| Normal-vs-Extreme_Obese |
3.782200E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.278600E-01 |
| Normal_Weight-vs-Obese |
3.702800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.885200E-01 |
| Extreme_Weight-vs-Obese |
2.385600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.022400E-01 |
| Obese-vs-Extreme_Obese |
3.502800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.545000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.744300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.978500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.008800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.357400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.999500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.534000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.882600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.312630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.107600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.481700E-03 |
| Normal-VS-Type2 PRCC |
2.81030000004456E-06 |
| Normal-VS-KIRP CIMP |
5.259400E-01 |
| Normal-VS-Unclassified PRCC |
7.055100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.758900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.240830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.290800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.817700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.260450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.014630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.647790E-04 |
| Normal-vs-N1 |
4.242000E-02 |
| Normal-vs-N2 |
9.810800E-01 |
| N0-vs-N1 |
3.668400E-01 |
| N0-vs-N2 |
1.260050E-01 |
| N1-vs-N2 |
3.708000E-01 |
|
|
